BillionToOne · 5 months ago
Vice President of Medical Affairs and Clinical Development, Oncology
BillionToOne is a next-generation molecular diagnostics company focused on transforming healthcare through innovative diagnostic solutions. They are seeking a Vice President of Medical Affairs, Oncology to lead medical affairs and clinical development initiatives, ensuring the successful execution of strategies that enhance provider adoption and clinical differentiation in oncology diagnostics.
BiotechnologyGeneticsHealth DiagnosticsMedical
Responsibilities
Lead the MSL function to drive provider engagement, medical education, and scientific communications in support of commercial and access efforts
Design and execute clinical trials that generate robust evidence for guideline inclusion, regulatory milestones, and payer coverage
Oversee the generation of clinically actionable insights and high-impact publications based on study and real-world data
Collaborate closely with Product, Commercial, R&D, Market Access, and Regulatory teams to ensure that medical strategy supports business outcomes
Hire, mentor, and develop high-performing leaders across the medical, clinical, and translational teams
Qualification
Required
M.D. degree required; must be a board-certified Medical Oncologist
5+ years of leadership experience in medical affairs and clinical development within oncology
Proven track record of designing and executing clinical studies for diagnostics and/or therapeutics
Deep knowledge of medical education, payer evidence requirements, and regulatory expectations
Exceptional scientific communication and cross-functional leadership skills
Thrives in fast-paced, entrepreneurial environments
Preferred
M.D./Ph.D. strongly preferred
Benefits
Multiple medical benefit options; employee premiums paid 100% of select plans, dependents covered up to 80%
Extremely generous Family Bonding Leave for new parents (16 weeks, paid at 100%)
Free UNITY Complete NIPT testing for employees & spouses
Supplemental fertility benefits coverage
Retirement savings program including a 4% Company match
Increase paid time off with increased tenure
Latest and greatest hardware (laptop, lab equipment, facilities)
Free daily on-site lunches provided from top eateries
A variety of perks on campus (state of the art gym, restaurant)
Free on-site EV charging (compatible with all EVs, including Tesla)
Company
BillionToOne
BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.
Funding
Current Stage
Public CompanyTotal Funding
$425.9MKey Investors
Premji InvestBridge BankHummingbird Ventures
2025-11-06IPO
2024-06-21Series D· $130M
2022-12-15Series C· $48.5M
Leadership Team
Recent News
Norwest
2025-12-31
Company data provided by crunchbase